Genetic changes within a tumor may alter response to therapy. Testing of an individual patients tumor for therapeutic vulnerabilities may provide more precise therapy planning.
The molecular genetic determinants of cancer therapy responses remains key to providing the right therapy at the right time.
Our open, collaborative, culture provides support to enable cutting-edge work on molecular genetics for treatment-resistant cancers.
3805 Old Easton Road, Doylestown, Pennsylvania 18902, United States
Monday - Friday: 8:00am - 5:00pm
Saturday - Sunday: Closed
Copyright © 2023 Ecogenome - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.